insights_auto
Nega EDIT tushdi 3,01%?
Batafsil oʻrganishchevron_right
EDIT:NASDAQ
Editas Medicine Inc
1,77 US$
arrow_downward
-3,01%(-0,055) 1K
1,78 US$
arrow_upward
+0,58% (+0,010)bedtimeYopilgandan keyin
Savdolar yopilgan: 18-noy, 16:00:01 (GMT-5) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoEDIT tikeri uchun statistika yaratilmoqda...
Ochish
1,86 US$
Yuqori
1,94 US$
Past
1,76 US$
Bozor kapitali
272,43 mln
Oʻrtacha hajm
2,39 mln
Hajmi
1,99 mln
52 haftalik eng yuqori
3,94 US$
52 haftalik eng past
1,66 US$
Aksiya boʻyicha daromad
-0,62 US$
Beta
2,09
Muomaladagi aksiyalar
154,34 mln
Xodimlar soni
87
Ochish
1,86 US$
Yuqori
1,94 US$
Past
1,76 US$
Bozor kapitali
272,43 mln
Oʻrtacha hajm
2,39 mln
Hajmi
1,99 mln
52 haftalik eng yuqori
3,94 US$
52 haftalik eng past
1,66 US$
Aksiya boʻyicha daromad
-0,62 US$
Beta
2,09
Muomaladagi aksiyalar
154,34 mln
Xodimlar soni
87
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
The Motley Fool
·
1 soat oldin
Stock Market Today, Nov. 18: S&P 500 Breaks Key Support as Fed Minutes Signal More Rate Hikes Ahead
Los Angeles Times
·
2 soat oldin
A fifth straight drop for the S&P 500 drags Wall Street to its longest losing streak since June
Hedgeye
·
9 soat oldin
Why Negative Gamma Has Taken the Brakes Off the S&P 500
US News Money
·
2 soat oldin
10 Best S&P 500 Stocks to Buy | Investing
Profil
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
Editas Medicine Inc haqida
CEO-
Xodimlar soni87
Asos solingannoy 2013
Bosh ofislar-
SektorHealth Care
Soha-
Veb-sayteditasmedicine.com